Endowment Wealth Management, Inc. - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 66 filers reported holding HUMACYTE INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Endowment Wealth Management, Inc. ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$285,728
-10.6%
97,5180.0%0.26%
-12.3%
Q2 2023$319,481
+7.0%
97,518
+0.9%
0.29%
-2.3%
Q1 2023$298,550
+46.4%
96,6180.0%0.30%
+33.9%
Q4 2022$203,864
-35.3%
96,6180.0%0.22%
-41.4%
Q3 2022$315,000
+1.6%
96,6180.0%0.38%
+2.4%
Q2 2022$310,000
-54.5%
96,6180.0%0.37%
-48.0%
Q1 2022$682,000
-2.6%
96,6180.0%0.72%
+1.3%
Q4 2021$700,00096,6180.71%
Other shareholders
HUMACYTE INC shareholders Q4 2021
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders